Neural Therapeutics Inc. (CSE:NURL)
Canada flag Canada · Delayed Price · Currency is CAD
0.0300
0.00 (0.00%)
At close: Jul 18, 2025

Neural Therapeutics Balance Sheet

Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Apr '25 Jul '24 Jul '23 Jul '22
Cash & Equivalents
0.250.070.270.37
Cash & Short-Term Investments
0.250.070.270.37
Cash Growth
971.82%-75.56%-26.50%-
Other Receivables
0.040.030.070.05
Receivables
0.040.030.070.05
Prepaid Expenses
0.02-0.010.03
Other Current Assets
-0--
Total Current Assets
0.320.10.350.45
Total Assets
0.320.10.350.45
Accounts Payable
0.040.060.170.18
Accrued Expenses
0.130.230.30.15
Short-Term Debt
-0.01--
Other Current Liabilities
---0.14
Total Current Liabilities
0.170.310.470.46
Long-Term Debt
0.740.370.14-
Other Long-Term Liabilities
-0.1--
Total Liabilities
0.910.780.610.46
Common Stock
3.522.912.312.07
Retained Earnings
-5.33-4.14-3.47-2.39
Comprehensive Income & Other
1.220.540.890.32
Shareholders' Equity
-0.59-0.68-0.26-0.01
Total Liabilities & Equity
0.320.10.350.45
Total Debt
0.740.380.14-
Net Cash (Debt)
-0.49-0.320.130.37
Net Cash Growth
---64.04%-
Net Cash Per Share
-0.01-0.010.000.01
Filing Date Shares Outstanding
88.765.7765.7736.77
Total Common Shares Outstanding
88.765.7745.0736.77
Working Capital
0.14-0.21-0.12-0.01
Book Value Per Share
-0.01-0.01-0.01-0.00
Tangible Book Value
-0.59-0.68-0.26-0.01
Tangible Book Value Per Share
-0.01-0.01-0.01-0.00
Source: S&P Global Market Intelligence. Standard template. Financial Sources.